Company Filing History:
Years Active: 2024
Title: Innovations by Eduardo Mar in Diabetic Neuropathy Treatment
Introduction
Eduardo Mar is an accomplished inventor based in Northbrook, IL (US). He has made significant contributions to the field of medicine, particularly in the treatment of painful diabetic peripheral neuropathy (DPN). His innovative approaches aim to improve the quality of life for patients suffering from this debilitating condition.
Latest Patents
Eduardo Mar holds a patent for "Methods of treating painful diabetic peripheral neuropathy." This patent outlines methods for treating advanced painful DPN by administering an effective amount of NYX-2925 or a pharmaceutically acceptable salt thereof. Additionally, the patent includes crystalline forms of 3-hydroxy-2-(5-isobutyryl-1-oxo-2,5-diazaspiro[3,4]octan-2-yl)butanamide. This innovative treatment has the potential to provide relief to many patients.
Career Highlights
Eduardo Mar is currently associated with Tenacia Biotechnology (Hong Kong) Co., Limited. His work at this company focuses on developing advanced therapeutic solutions for various medical conditions. With a patent portfolio that includes one patent, he continues to push the boundaries of medical innovation.
Collaborations
Eduardo collaborates with notable professionals in his field, including M Amin Khan and Mohsen Arghavani. These partnerships enhance the research and development efforts at Tenacia Biotechnology, fostering an environment of innovation and discovery.
Conclusion
Eduardo Mar's contributions to the treatment of painful diabetic peripheral neuropathy exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also offers hope to patients in need of effective treatments.